National Pension Service Trims Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

National Pension Service cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 15.6% during the fourth quarter, HoldingsChannel reports. The firm owned 87,600 shares of the biotechnology company’s stock after selling 16,200 shares during the period. National Pension Service’s holdings in Axon Enterprise were worth $52,062,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Lake Street Advisors Group LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $225,000. Illinois Municipal Retirement Fund lifted its holdings in shares of Axon Enterprise by 94.2% in the fourth quarter. Illinois Municipal Retirement Fund now owns 13,293 shares of the biotechnology company’s stock valued at $7,900,000 after purchasing an additional 6,449 shares in the last quarter. Los Angeles Capital Management LLC lifted its holdings in shares of Axon Enterprise by 482.3% in the fourth quarter. Los Angeles Capital Management LLC now owns 10,330 shares of the biotechnology company’s stock valued at $6,139,000 after purchasing an additional 8,556 shares in the last quarter. Synergy Financial Group LTD lifted its holdings in shares of Axon Enterprise by 32.9% in the fourth quarter. Synergy Financial Group LTD now owns 993 shares of the biotechnology company’s stock valued at $590,000 after purchasing an additional 246 shares in the last quarter. Finally, IFP Advisors Inc lifted its stake in shares of Axon Enterprise by 7.6% during the fourth quarter. IFP Advisors Inc now owns 952 shares of the biotechnology company’s stock valued at $566,000 after buying an additional 67 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Barclays set a $726.00 price target on shares of Axon Enterprise and gave the stock an “overweight” rating in a research report on Thursday. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a research report on Thursday, February 20th. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Finally, The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the transaction, the president now owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This represents a 0.70 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,711 shares of company stock valued at $5,631,561. Insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $525.63 on Friday. The business’s 50-day moving average price is $611.62 and its two-hundred day moving average price is $522.09. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company has a market capitalization of $40.08 billion, a P/E ratio of 135.82, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.